Salakhov Edward, Tikhonova Lilia, Southwick Karen, Shakarishvili Anna, Ryan Caroline, Hillis Susan
Ministry of Health of the Russian Federation, St. Petersburg, Russia.
Sex Transm Dis. 2004 Feb;31(2):127-32. doi: 10.1097/01.OLQ.0000109516.47951.B8.
Congenital syphilis (CS) reports in Russia increased 26-fold from 1991 to 1999. Case reports included only infants who were clinical cases, had persistent serologic changes, or confirmed syphilitic stillbirth. Although not reported, policies stipulate that infants of inadequately treated or untreated mothers receive preventive penicillin treatment.
We examined whether risk factors and consequences for epidemiologic cases of CS (infants of inadequately treated mothers) resembled those of clinical cases and differed from those of noncases (infants of adequately treated mothers).
A retrospective record review from Maternity Houses in 5 sites identified 715 syphilis-infected women who gave birth.
Among women with maternal syphilis, 11% (n = 81) of infants were clinical cases, 56% (n = 402) were epidemiologic cases, and 33% (n = 232) were noncases of CS. Compared with noncases, maternal risk factors for epidemiologic cases included nonresidence (P <0.01), late syphilis (P <0.01), unemployment (P <0.01), no prenatal care (P <0.01), and syphilis testing at >/=28 weeks (P <0.01). Each of these was also significant for being a clinical case. Associated consequences of CS for the epidemiologic cases included increases in stillbirth (P <0.01), preterm birth (P <0.01), low birth weight (P <0.01), transfer to a pediatric hospital (P <0.01), and abandonment (P <0.05). Each of these except stillbirth was significantly elevated among clinical cases. Nearly half of the epidemiologic cases had no record of any penicillin treatment for the infant. Epidemiologic cases were significantly more likely than noncases to have no clinical or laboratory follow up.
In Russia, maternal risk factors and perinatal consequences for epidemiologic cases of CS resembled those of clinical cases. Expanding national reporting to include epidemiologic cases would strengthen CS prevention and monitoring.
1991年至1999年期间,俄罗斯先天性梅毒(CS)报告病例增加了26倍。病例报告仅包括临床病例、血清学持续变化或确诊梅毒死产的婴儿。尽管未作报告,但政策规定,母亲治疗不充分或未接受治疗的婴儿应接受预防性青霉素治疗。
我们研究了CS流行病学病例(母亲治疗不充分的婴儿)的危险因素和后果是否与临床病例相似,以及是否与非病例(母亲治疗充分的婴儿)不同。
对5个地点的妇产医院进行回顾性记录审查,确定了715名感染梅毒的分娩妇女。
在患有母亲梅毒的妇女中,11%(n = 81)的婴儿为临床病例,56%(n = 402)为流行病学病例,33%(n = 232)为非CS病例。与非病例相比,流行病学病例的母亲危险因素包括不住在当地(P <0.01)、梅毒晚期(P <0.01)、失业(P <0.01)、未接受产前护理(P <0.01)以及在≥28周时进行梅毒检测(P <0.01)。这些因素对于成为临床病例也都具有显著性。CS对流行病学病例的相关后果包括死产增加(P <0.01)、早产(P <0.01)、低出生体重(P <0.01)、转至儿科医院(P <0.01)以及被遗弃(P <0.05)。除死产外,这些情况在临床病例中均显著增加。近一半的流行病学病例没有婴儿接受任何青霉素治疗的记录。流行病学病例比非病例更有可能没有临床或实验室随访。
在俄罗斯,CS流行病学病例的母亲危险因素和围产期后果与临床病例相似。扩大国家报告范围以纳入流行病学病例将加强CS的预防和监测。